Rodriguez Raul R's Form 4 filing
Rigel Pharmaceuticals Inc (RIGL) · filed Feb 6, 2024
- Accession no.
- 0000905148-24-000445
- Filed
- Feb 6, 2024
- Trade date
- Feb 2-5, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $60.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rodriguez Raul RCIK 0001190279 | Director, Officer (CEO, President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2024 | Common Stock | SSaleDisposed | −22,349 | $1.13 | −$25,254.37 | 2,067,174 | Direct | |
| Feb 5, 2024 | Common Stock | SSaleDisposed | −30,545 | $1.14 | −$34,821.3 | 2,036,629 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.